Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Keith McCrae MD

Keith R. McCrae MD

Director, Benign Hematology, Taussig Cancer Institute; Staff, Department of Vascular Medicine, Heart and Vascular Institute; Professor of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio

Keith McCrae is Director of Benign Hematology in the Taussig Cancer Institute and a Professor of Molecular Medicine in the Lerner Research Institute at Cleveland Clinic.


Dr. McCrae has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Immune Thrombocytopenia and Pregnancy